CM Life Sciences, Inc.
c/o Corvex Management LP
667 Madison Avenue
New York, New York 10065
August 28, 2020
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
|Re:||CM Life Sciences, Inc.|
|Registration Statement on Form S-1|
|Filed August 14, 2020, as amended|
|File No. 333-246251|
Dear Ms. Dorin:
Pursuant to Rule 461 of the rules and regulations promulgated under the Securities Act of 1933, as amended, CM Life Sciences, Inc. respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. Washington D.C. time on September 1, 2020, or as soon thereafter as practicable.
Please call Colin Diamond of White & Case LLP at (212) 819-8754 to provide notice of the effectiveness of the Registration Statement.
[Signature Page Follows]
|Very truly yours,|
|CM Life Sciences, Inc.|
|By:||/s/ Brian Emes|
|Title:||Chief Financial Officer and Secretary|
|cc:||Colin Diamond, White & Case LLP|
|Joel Rubinstein, White & Case LLP|
|cc:||Gregg Noel, Skadden, Arps, Slate, Meagher & Flom LLP|
|Michael Mies, Skadden, Arps, Slate, Meagher & Flom LLP|